Developer docs
API playgroundTry for free, no card

Search company profiles

Electromed

Full company profile

uuid022f5b8

Namestring
Electromed
Legal namestring
Electromed, Inc.
Websiteurl
smartvest.com
Company typeenum
Public
Founded yearint
1992
Descriptiontext

Electromed, Inc. is a New Prague, Minnesota-based medical device company founded in 1992 and publicly traded on the NYSE under ticker ELMD. The company singularly focuses on High Frequency Chest Wall Oscillation (HFCWO) therapy, delivered through its SmartVest Airway Clearance System. The core product consists of a generator that delivers rapidly repeating air pulses through a wearable vest garment, loosening and mobilizing mucus to break the cycle of infection and inflammation in chronic lung conditions. The portfolio includes the SmartVest Clearway generator (compact 13.3 lb touchscreen device with wheeled carrier), SmartVest Connect Bluetooth mobile app for therapy tracking, and garment accessories in multiple sizes and colors. All products carry a lifetime warranty and are engineered and manufactured in Minnesota.

The company serves primarily adult patients with bronchiectasis and COPD, with secondary segments in cystic fibrosis and veterans with service-related respiratory conditions. Distribution is prescription-only through clinicians, with the company handling prior authorization and reimbursement support; products are covered by Medicare, Medicaid, most private insurers, and the VA. Electromed holds a GSA contract (V797P-4033B) for government purchasing and partners with Marathon Medical, a veteran-owned distributor, to facilitate VA access. The commercial motion combines enterprise field sales to clinicians, inside sales via Patient Care Advocates (Respiratory Therapists), and content-led patient education through the SmartVest website and social channels.

The business model is durable medical equipment hardware sales with reimbursement-driven ASPs. Pricing is not publicly disclosed. Clinical evidence underpins commercialization: published studies report a 57% reduction in antibiotic use, 59% reduction in hospitalizations, 60% reduction in emergency department visits, 68% improved quality of life, and 97% of patients reporting feeling better after use, with 42% sustained hospitalization reduction over 2.5 years of therapy. Operations are domestic-only, with no disclosed subsidiaries, M&A activity, or external funding rounds, consistent with a stable, single-category, public small-cap medtech.

Short descriptiontext

Electromed manufactures and sells the SmartVest Airway Clearance System, a High Frequency Chest Wall Oscillation (HFCWO) prescription device for adults with chronic lung conditions such as bronchiectasis and COPD, distributed via clinicians and Medicare, Medicaid, private insurance, and the VA.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersNew Prague, United States
HQ citystring
New Prague
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
airway clearance therapy, HFCWO therapy devices, respiratory medical devices, bronchiectasis treatment, durable medical equipment
Industry3 codes
PRIMARYHLAHAGAJ
Chest Physiotherapy & Airway Clearance Devices (PEP, Oscillatory PEP, HFCWO, Cough Assist)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHSABAKAD
Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers)
Home & Personal Services/Elder Care & In-Home Care Services/Medical Equipment & Home Mobility Support Services
SECONDARYHLAKANAM
Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Respiratory Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1SmartVest HFCWO Device Sales
TypeHardware Sales
Description

The company sells SmartVest Airway Clearance Systems including generators and wearable vest garments. Products are covered by most private insurance, Medicare, Medicaid, and VA benefits. Available by prescription only as a durable medical equipment device.

smartvest.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1SmartVest
Description

Primary brand name for the SmartVest Airway Clearance System, a high frequency chest wall oscillation (HFCWO) therapy device for treating chronic lung conditions like bronchiectasis and COPD.

smartvest.com:443
+3 more records
Core offering1 text field

Electromed designs, manufactures, and sells the SmartVest Airway Clearance System, a High-Frequency Chest Wall Oscillation (HFCWO) vest that delivers rapidly repeating pulses of air to loosen and mobilize mucus for patients with chronic lung conditions such as bronchiectasis and COPD. The system is sold by prescription as durable medical equipment, reimbursed through Medicare, Medicaid, private insurance, and VA benefits, and supported by Patient Care Advocates (Respiratory Therapists) and a clinician-facing reimbursement team. The portfolio includes the SmartVest Airway Clearance System, the portable SmartVest Clearway generator, the SmartVest Connect mobile app, garments in multiple sizes and colors, and a wheeled carrier.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 57% decrease in antibiotic use
+7 more records
Product overview1 text field

Electromed's SmartVest is a dedicated HFCWO (High-Frequency Chest Wall Oscillation) therapy system for airway clearance. The portfolio consists of the core SmartVest Airway Clearance System (comprising a garment vest and generator), the portable SmartVest Clearway generator, the SmartVest Connect mobile app for Bluetooth-connected therapy tracking, and SmartVest garment accessories available in multiple colors and sizes. Backed by a lifetime warranty, the system is engineered and manufactured in Minnesota.

Product and service5 records
1SmartVest Airway Clearance System
CategoryRespiratory medical device (durable medical equipment)
Description

High-Frequency Chest Wall Oscillation (HFCWO) vest system that delivers rapidly repeating air pulses to loosen and propel mucus toward larger airways for easier expectoration. Sold by prescription for adults with chronic lung conditions such as bronchiectasis and COPD, and covered by Medicare, Medicaid, private insurance, and VA benefits. Backed by a lifetime warranty on generators, garments, and accessories.

2SmartVest Clearway
CategoryRespiratory medical device (durable medical equipment)
Description

Modern HFCWO generator with an intuitive touchscreen interface, small size, and light weight (13.3 lbs) designed for portability and convenient travel. Paired with the SmartVest garment and SmartVest Connect mobile app for Bluetooth-connected therapy tracking. Sold by prescription as durable medical equipment.

3SmartVest Connect
CategoryMobile application (therapy tracking software)
Description

Mobile application that pairs via Bluetooth with the SmartVest device, enabling users to track therapy performance, view historical metrics, leave notes for clinicians, and log sessions daily. Accessible from smartphone, desktop, or tablet.

4SmartVest Garment
CategoryRespiratory medical device accessory (durable medical equipment)
Description

Breathable, machine-washable vest garment component of the SmartVest Airway Clearance System. Available in multiple colors (red, black, pink, blue, purple) and eight sizes covering chest circumferences from 15 to 68 inches (X-Small to XX-Large). Backed by a lifetime warranty.

5SmartVest Wheeled Carrier
CategoryRespiratory medical device accessory (durable medical equipment)
Description

Compact wheeled carrier with a telescoping handle designed for easy transport and storage of the SmartVest Clearway generator, supporting portability for travel and daily use.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

SmartVest has partnered with Marathon Medical, a veteran-owned company, to provide faster, more effective solutions for veterans managing respiratory conditions like COPD and bronchiectasis. This partnership streamlines the ordering process for eligible veterans through the VA system.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Philips Respironics is a dominant respiratory care incumbent offering CPAP/BiPAP, ventilators, oxygen therapy, and HFCWO (via RespirTech). It competes with Electromed in broader hospital and home respiratory accounts, though airway clearance is only one of many product lines in its portfolio.

2Drägerwerk
TypeOthers
Description

Drägerwerk is a German medical and safety technology company with a respiratory care portfolio spanning ventilators, anesthesia, and neonatal care. While not directly competing in HFCWO, it is a relevant adjacent player in the broader hospital respiratory ecosystem where SmartVest competes for prescriber attention and ICU step-down discharge planning.

TypeDirect peer
Description

Monaghan Medical manufactures Acapella and Aerobika, leading positive expiratory pressure (PEP) and oscillatory PEP airway clearance devices. While a different modality than HFCWO, they compete for the same airway clearance therapy prescriptions in bronchiectasis and COPD patients, often serving as the first-line alternative before HFCWO escalation.

TypeBroad incumbent
Description

ResMed is a global leader in sleep and respiratory care, with primary focus on CPAP, BiPAP, and connected health for sleep apnea and COPD. While not a direct HFCWO competitor, it operates in the same pulmonology prescribing channel and competes for connected respiratory patient-monitoring mindshare.

TypeDirect peer
Description

RespirTech manufactures the inCourage Airway Clearance System, a directly competing HFCWO vest device referenced by Electromed in its comparative performance claims (SmartVest releases 21% more air than inCourage). Acquired by Philips in 2017, it is the closest like-for-like competitor in the prescription HFCWO market.

TypeBroad incumbent
Description

Baxter acquired Hill-Rom in 2021 and now markets The Vest 3 HFCWO system as part of a broad medical device portfolio. It competes with Electromed at the enterprise hospital purchasing level, leveraging broader medtech contracts to bundle airway clearance devices with other capital equipment.

TypeDirect peer
Description

PARI manufactures respiratory therapy devices including aerosol delivery and airway clearance systems used by the same chronic lung disease patient population as SmartVest. They compete for pulmonologist and respiratory therapist mindshare in the bronchiectasis and COPD therapeutic pathway.

TypeDirect peer
Description

AffloVest is a portable, battery-operated HFCWO vest system manufactured by International Biophysics Corporation. It targets the same bronchiectasis, COPD, and cystic fibrosis patients as SmartVest but differentiates through cordless portability, serving patients who need greater mobility during therapy.

TypeEmerging player
Description

Vyaire Medical is a respiratory diagnostics and ventilation company spun out of Becton Dickinson. While focused on pulmonary function testing and ventilation rather than HFCWO, it intersects with Electromed's clinician channel through pulmonology practices and respiratory therapy departments.

TypeDirect peer
Description

Hill-Rom (acquired by Baxter in 2021) manufactures The Vest Airway Clearance System, including the current The Vest 3 model, a direct HFCWO competitor also referenced in SmartVest's comparative performance claims (15% less air release than SmartVest). Competes head-to-head for the same patient population and reimbursement pathways.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Electromed

Respiratory Medical Devicessmartvest.com

Electromed manufactures and sells the SmartVest Airway Clearance System, a High Frequency Chest Wall Oscillation (HFCWO) prescription device for adults with chronic lung conditions such as bronchiectasis and COPD, distributed via clinicians and Medicare, Medicaid, private insurance, and the VA.

What Electromed does

Electromed, Inc. is a New Prague, Minnesota-based medical device company founded in 1992 and publicly traded on the NYSE under ticker ELMD. The company singularly focuses on High Frequency Chest Wall Oscillation (HFCWO) therapy, delivered through its SmartVest Airway Clearance System. The core product consists of a generator that delivers rapidly repeating air pulses through a wearable vest garment, loosening and mobilizing mucus to break the cycle of infection and inflammation in chronic lung conditions. The portfolio includes the SmartVest Clearway generator (compact 13.3 lb touchscreen device with wheeled carrier), SmartVest Connect Bluetooth mobile app for therapy tracking, and garment accessories in multiple sizes and colors. All products carry a lifetime warranty and are engineered and manufactured in Minnesota.

The company serves primarily adult patients with bronchiectasis and COPD, with secondary segments in cystic fibrosis and veterans with service-related respiratory conditions. Distribution is prescription-only through clinicians, with the company handling prior authorization and reimbursement support; products are covered by Medicare, Medicaid, most private insurers, and the VA. Electromed holds a GSA contract (V797P-4033B) for government purchasing and partners with Marathon Medical, a veteran-owned distributor, to facilitate VA access. The commercial motion combines enterprise field sales to clinicians, inside sales via Patient Care Advocates (Respiratory Therapists), and content-led patient education through the SmartVest website and social channels.

The business model is durable medical equipment hardware sales with reimbursement-driven ASPs. Pricing is not publicly disclosed. Clinical evidence underpins commercialization: published studies report a 57% reduction in antibiotic use, 59% reduction in hospitalizations, 60% reduction in emergency department visits, 68% improved quality of life, and 97% of patients reporting feeling better after use, with 42% sustained hospitalization reduction over 2.5 years of therapy. Operations are domestic-only, with no disclosed subsidiaries, M&A activity, or external funding rounds, consistent with a stable, single-category, public small-cap medtech.

Electromed firmographics

Firmographics
Name
Electromed
Legal name
Electromed, Inc.
Website
https://smartvest.com
Company type
Public
Founded year
1992
Operating status
Operating
Short description
Electromed manufactures and sells the SmartVest Airway Clearance System, a High Frequency Chest Wall Oscillation (HFCWO) prescription device for adults with chronic lung conditions such as bronchiectasis and COPD, distributed via clinicians and Medicare, Medicaid, private insurance, and the VA.
Ownership category
akta.pro rank

Electromed industry classification

Industry
Product category
Respiratory Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAGAJ
Chest Physiotherapy & Airway Clearance Devices (PEP, Oscillatory PEP, HFCWO, Cough Assist)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHSABAKAD
Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers)
Home & Personal Services/Elder Care & In-Home Care Services/Medical Equipment & Home Mobility Support Services
SECONDARYHLAKANAM
Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management

Keywords

  • Airway clearance therapy
  • HFCWO therapy devices
  • Respiratory medical devices
  • Bronchiectasis treatment
  • Durable medical equipment

Where Electromed is headquartered

Location

Headquarters

HQ city
New Prague
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Electromed business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. SmartVest HFCWO Device Sales: The company sells SmartVest Airway Clearance Systems including generators and wearable vest garments. Products are covered by most private insurance, Medicare, Medicaid, and VA benefits. Available by prescription only as a durable medical equipment device.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Electromed product offering

Product offering

Core offering

Electromed designs, manufactures, and sells the SmartVest Airway Clearance System, a High-Frequency Chest Wall Oscillation (HFCWO) vest that delivers rapidly repeating pulses of air to loosen and mobilize mucus for patients with chronic lung conditions such as bronchiectasis and COPD. The system is sold by prescription as durable medical equipment, reimbursed through Medicare, Medicaid, private insurance, and VA benefits, and supported by Patient Care Advocates (Respiratory Therapists) and a clinician-facing reimbursement team. The portfolio includes the SmartVest Airway Clearance System, the portable SmartVest Clearway generator, the SmartVest Connect mobile app, garments in multiple sizes and colors, and a wheeled carrier.

Product overview

Electromed's SmartVest is a dedicated HFCWO (High-Frequency Chest Wall Oscillation) therapy system for airway clearance. The portfolio consists of the core SmartVest Airway Clearance System (comprising a garment vest and generator), the portable SmartVest Clearway generator, the SmartVest Connect mobile app for Bluetooth-connected therapy tracking, and SmartVest garment accessories available in multiple colors and sizes. Backed by a lifetime warranty, the system is engineered and manufactured in Minnesota.

Differentiator

Problem solved

Functional benefit

Brands

  • SmartVest: Primary brand name for the SmartVest Airway Clearance System, a high frequency chest wall oscillation (HFCWO) therapy device for treating chronic lung conditions like bronchiectasis and COPD.
  • SmartVest Clearway
  • SmartVest SQL
  • SmartVest Connect

Products and services

  • SmartVest Airway Clearance System High-Frequency Chest Wall Oscillation (HFCWO) vest system that delivers rapidly repeating air pulses to loosen and propel mucus toward larger airways for easier expectoration. Sold by prescription for adults with chronic lung conditions such as bronchiectasis and COPD, and covered by Medicare, Medicaid, private insurance, and VA benefits. Backed by a lifetime warranty on generators, garments, and accessories.
  • SmartVest Clearway Modern HFCWO generator with an intuitive touchscreen interface, small size, and light weight (13.3 lbs) designed for portability and convenient travel. Paired with the SmartVest garment and SmartVest Connect mobile app for Bluetooth-connected therapy tracking. Sold by prescription as durable medical equipment.
  • SmartVest Connect Mobile application that pairs via Bluetooth with the SmartVest device, enabling users to track therapy performance, view historical metrics, leave notes for clinicians, and log sessions daily. Accessible from smartphone, desktop, or tablet.
  • SmartVest Garment Breathable, machine-washable vest garment component of the SmartVest Airway Clearance System. Available in multiple colors (red, black, pink, blue, purple) and eight sizes covering chest circumferences from 15 to 68 inches (X-Small to XX-Large). Backed by a lifetime warranty.
  • SmartVest Wheeled Carrier Compact wheeled carrier with a telescoping handle designed for easy transport and storage of the SmartVest Clearway generator, supporting portability for travel and daily use.

Quantifiable outcome

  • 57% decrease in antibiotic use
  • +7 more outcomes

Companies that use Electromed

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Electromed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Electromed partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Marathon MedicalcoreChannel Partner/ Reseller/ DistributorSmartVest has partnered with Marathon Medical, a veteran-owned company, to provide faster, more effective solutions for veterans managing respiratory conditions like COPD and bronchiectasis. This partnership streamlines the ordering process for eligible veterans through the VA system.

Scale indicators7 records

Recent moves5 records

Expansion highlights4 records

Electromed competitors and assessment

Company assessment

Broad incumbents

  • Philips Respironics: Philips Respironics is a dominant respiratory care incumbent offering CPAP/BiPAP, ventilators, oxygen therapy, and HFCWO (via RespirTech). It competes with Electromed in broader hospital and home respiratory accounts, though airway clearance is only one of many product lines in its portfolio.
  • ResMed: ResMed is a global leader in sleep and respiratory care, with primary focus on CPAP, BiPAP, and connected health for sleep apnea and COPD. While not a direct HFCWO competitor, it operates in the same pulmonology prescribing channel and competes for connected respiratory patient-monitoring mindshare.
  • Baxter International: Baxter acquired Hill-Rom in 2021 and now markets The Vest 3 HFCWO system as part of a broad medical device portfolio. It competes with Electromed at the enterprise hospital purchasing level, leveraging broader medtech contracts to bundle airway clearance devices with other capital equipment.

Others

  • Drägerwerk: Drägerwerk is a German medical and safety technology company with a respiratory care portfolio spanning ventilators, anesthesia, and neonatal care. While not directly competing in HFCWO, it is a relevant adjacent player in the broader hospital respiratory ecosystem where SmartVest competes for prescriber attention and ICU step-down discharge planning.

Direct peers

  • Monaghan Medical: Monaghan Medical manufactures Acapella and Aerobika, leading positive expiratory pressure (PEP) and oscillatory PEP airway clearance devices. While a different modality than HFCWO, they compete for the same airway clearance therapy prescriptions in bronchiectasis and COPD patients, often serving as the first-line alternative before HFCWO escalation.
  • RespirTech (Philips): RespirTech manufactures the inCourage Airway Clearance System, a directly competing HFCWO vest device referenced by Electromed in its comparative performance claims (SmartVest releases 21% more air than inCourage). Acquired by Philips in 2017, it is the closest like-for-like competitor in the prescription HFCWO market.
  • PARI Respiratory Equipment: PARI manufactures respiratory therapy devices including aerosol delivery and airway clearance systems used by the same chronic lung disease patient population as SmartVest. They compete for pulmonologist and respiratory therapist mindshare in the bronchiectasis and COPD therapeutic pathway.
  • AffloVest (International Biophysics): AffloVest is a portable, battery-operated HFCWO vest system manufactured by International Biophysics Corporation. It targets the same bronchiectasis, COPD, and cystic fibrosis patients as SmartVest but differentiates through cordless portability, serving patients who need greater mobility during therapy.
  • Hill-Rom / Baxter (The Vest): Hill-Rom (acquired by Baxter in 2021) manufactures The Vest Airway Clearance System, including the current The Vest 3 model, a direct HFCWO competitor also referenced in SmartVest's comparative performance claims (15% less air release than SmartVest). Competes head-to-head for the same patient population and reimbursement pathways.

Emerging players

  • Vyaire Medical: Vyaire Medical is a respiratory diagnostics and ventilation company spun out of Becton Dickinson. While focused on pulmonary function testing and ventilation rather than HFCWO, it intersects with Electromed's clinician channel through pulmonology practices and respiratory therapy departments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Electromed social profiles

Digital presence

Electromed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Electromed leadership team

Management profile

Number of profiles

Electromed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Electromed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Electromed

What does Electromed do?

Electromed designs, manufactures, and sells the SmartVest Airway Clearance System, a High-Frequency Chest Wall Oscillation (HFCWO) vest that delivers rapidly repeating pulses of air to loosen and mobilize mucus for patients with chronic lung conditions such as bronchiectasis and COPD. The system is sold by prescription as durable medical equipment, reimbursed through Medicare, Medicaid, private insurance, and VA benefits, and supported by Patient Care Advocates (Respiratory Therapists) and a clinician-facing reimbursement team. The portfolio includes the SmartVest Airway Clearance System, the portable SmartVest Clearway generator, the SmartVest Connect mobile app, garments in multiple sizes and colors, and a wheeled carrier.

Is Electromed a public or private company?

Electromed is a public company. It is classified as public and is currently operating.

When was Electromed founded?

Electromed was founded in 1992.

Where is Electromed based?

Electromed is headquartered in New Prague, United States, in the North America region.

How does Electromed make money?

One revenue line is on record: smartVest HFCWO Device Sales.

Who are Electromed's main competitors?

Broad incumbents on record are Philips Respironics, ResMed and Baxter International. Drägerwerk is listed as an others. Direct peers are Monaghan Medical, RespirTech (Philips), PARI Respiratory Equipment, AffloVest (International Biophysics) and Hill-Rom / Baxter (The Vest). Vyaire Medical is listed as an emerging player.

Does Electromed have an API?

No public API is recorded for Electromed.

What industry is Electromed in?

Electromed's product category is Respiratory Medical Devices. Its primary akta.pro industry code is HLAHAGAJ, Chest Physiotherapy & Airway Clearance Devices (PEP, Oscillatory PEP, HFCWO, Cough Assist), with a secondary code of HSABAKAD, Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MoomooBetterInvestingTM Magazine Update on Electromed Inc. and Five Below Inc.BetterInvesting's committee named Electromed Inc. as "Stock to Study" and Five Below Inc. as "Undervalued Stock" for the January February 2027 issue. The selections are for informational and educational use only, not endorsements. The magazine is published by the National Association of Investors.PR NewswireBetterInvesting™ Magazine Update on Electromed Inc. and Five Below Inc.BetterInvesting's committee named Electromed Inc. as "Stock to Study" and Five Below Inc. as "Undervalued Stock" for the January February 2027 issue. The selections are for informational and educational use only, not endorsements. The magazine is a nonprofit investment education organization.Seeking AlphaElectromed, Inc. (ELMD) Q1 2027 Earnings Call TranscriptElectromed held its Q1 2027 earnings call on November 10, 2026, with CEO Jim Cunniff and CFO Brad Nagel. The company issued its quarterly results earlier that day, available on its website. The call included forward-looking statements about future performance.Investing.comEarnings call transcript: Electromed posts Q1 2026 EPS beat, shares slip after hoursElectromed reported Q1 fiscal 2027 EPS of $0.32, beating estimates, but revenue of $18.68 million missed forecasts. Net revenue rose 10.6% to $18.7 million, while operating income climbed 30.7% to $3.5 million. Shares fell 2.69% after hours, reflecting investor concern over the sales shortfall and channel weakness.BenzingaElectromed Q1 2027 Earnings Call Transcript - Electromed (AMEX:ELMD)Electromed reported Q1 fiscal 2027 revenue of $18.7 million, up 10.6% year-over-year, with diluted EPS of $0.32, a 28% increase. Home care revenue grew 17.6% while distributor and hospital revenues fell 56% and 32%, respectively. CEO Jim Cunniff announced his retirement in April 2027, with a succession plan underway.Business Wire BlogElectromed, Inc. to Report Q1 Fiscal 2027 Financial Results on November 10, 2026Electromed, Inc. will report its fiscal 2027 first-quarter results for the period ended September 30, 2026, on November 10, 2026, after market close. The company will host a conference call at 5:00 p.m. Eastern Time on the same day to discuss the results.MarketBeat41,544 Shares in Electromed, Inc. $ELMD Bought by Isthmus Partners LLCIsthmus Partners LLC acquired a new position in Electromed, buying 41,544 shares valued at about $1.17 million in Q3. The fund now holds roughly 0.50% of the company, and analysts rate Electromed a Moderate Buy with an average target price of $43.75.Investing.comElectromed at LD Micro Main Event: growth, margins and a CEO exitElectromed reported record Q4 and full-year revenue of about $75 million at its LD Micro conference, with gross margins in the high 70s and no debt. CEO Jim Cunniff said he will retire in April 2027, and the company sees a $3.1 billion U.S. opportunity in bronchiectasis treatment.American Banking and Market NewsAnalyzing Cytosorbents (NASDAQ:CTSO) and Electromed (NYSE:ELMD)Cytosorbents and Electromed are compared on risk, earnings, institutional ownership, dividends, analyst recommendations, valuation, and profitability. Electromed beats Cytosorbents on 12 of 14 factors, with higher revenue and earnings, while Cytosorbents has a lower P/E ratio and higher upside potential.